EUVIMEDEUVIMED entdecken
Crossref

Adopting the International Consensus on ANA Patterns (ICAP) classification for reporting: the experience of Italian clinical laboratories

Maria Infantino, Nicola Bizzaro, Wilson de Melo Cruvinel, Edward K L Chan, Luis E C Andrade iD

Clinical Chemistry and Laboratory Medicine (CCLM) · 2024

DOI: 10.1515/cclm-2023-0752 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Chemistry and Laboratory Medicine (CCLM), 2024. Verfasst von Maria Infantino und 4 weiteren Autor:innen. Beteiligte Einrichtung: Immunology and Allergy Laboratory, San Giovanni di Dio Hospital, Florence, Italy. Hauptthemen laut MEDLINE: Autoimmune Diseases, Rheumatic Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The indirect immunofluorescence assay on HEp-2 cells (HEp-2 IFA) is still considered the reference method to detect anti-nuclear antibodies (ANA) because of its high sensitivity and represents a relevant tool for the diagnosis of autoimmune rheumatic diseases. During the last decade, the International Consensus on ANA Patterns (ICAP) initiative promoted harmonization and understanding of HEp-2 IFA staining pattern nomenclature, as well as promoting their use in patient care by providing interpretation for HEp-2 IFA test results. In conjunction with a nationwide survey on the evolution of autoantibody diagnostics in autoimmune rheumatic diseases, we focused on the adherence of the Italian laboratories to the ICAP nomenclature analyzing its lights and shadows. The recent ICAP-oriented report, largely used today among Italian laboratories, also represents a further step in harmonizing and improving communication with the clinicians, adding value to laboratory findings and helping with critical clinical decisions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autoimmune DiseasesRheumatic DiseasesHumansLaboratories, ClinicalConsensusAntibodies, AntinuclearFluorescent Antibody Technique, IndirectItaly

Stichwörter der Autor:innen

ANA patternsANA reportHEp-2 cell indirect immunofluorescence assay (HEp-2 IFA)anti-cell antibodiesharmonizationinternational consensus on ANA patterns

Substanzen

Antibodies, Antinuclear

Autor:innen und Institutionen

  • Immunology and Allergy Laboratory, San Giovanni di Dio Hospital, Florence, Italy.
  • Laboratory of Clinical Pathology, Azienda Sanitaria Universitaria Integrata, Udine, Italy.
  • Pontifícia Universidade Católica de Goiás, Goîania, Brazil.
  • Department of Oral Biology, University of Florida, Gainesville, FL, USA.
  • Rheumatology Division, Escola Paulista de Medicina, Universidade Federal de Sao Paulo, Sao Paulo, Brazil.
  • Immunology Division, Fleury Medicine and Health Laboratories, Sao Paulo, Brazil.

ORCID-Profile: Luis E C Andrade

Zitieren

APA

Infantino, M., Bizzaro, N., de Melo Cruvinel, W., Chan, E. K. L., & Andrade, L. E. C. (2024). Adopting the International Consensus on ANA Patterns (ICAP) classification for reporting: the experience of Italian clinical laboratories. Clinical Chemistry and Laboratory Medicine (CCLM). https://doi.org/10.1515/cclm-2023-0752

Vancouver

Infantino M, Bizzaro N, de Melo Cruvinel W, Chan EKL, Andrade LEC. Adopting the International Consensus on ANA Patterns (ICAP) classification for reporting: the experience of Italian clinical laboratories. Clinical Chemistry and Laboratory Medicine (CCLM). 2024. doi:10.1515/cclm-2023-0752

BibTeX
@article{Infantino2024,
  author = {Infantino, Maria and Bizzaro, Nicola and de Melo Cruvinel, Wilson and Chan, Edward K L and Andrade, Luis E C},
  title = {Adopting the International Consensus on ANA Patterns (ICAP) classification for reporting: the experience of Italian clinical laboratories},
  journal = {Clinical Chemistry and Laboratory Medicine (CCLM)},
  year = {2024},
  doi = {10.1515/cclm-2023-0752}
}
Kostenlos starten →